Description
The past decade has seen an explosion of new information concerning the immunology, toxicology, and pharmacology of drug-induced liver disease. This expertly written Second Edition supplies an in-depth discussion of the recent developments in drug-induced hepatotoxicity, covering mechanisms, histopathology, management, risk factors, and specific toxins. Significantly updated, this source addresses new topics including pharmacogenomics, toxicogenomics, causality assessment, regulatory perspectives, and current management protocols for drug-induced liver disease.
